Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer and one of the leading causes of cancer-related death in the world. Due to the recurrence of HCC, its survival rate is still low. Therefore, it is vital to seek prognostic biomarkers for HCC. In this study, differential analysis was conducted on gene expression data in The Cancer Genome Atlas -LIHC, and 4482 differentially expressed genes in tumor tissue were selected. Then, weighted gene co-expression network analysis was used to analyze the co-expression of the gained differential genes. By module–trait correlation analysis, the turquoise gene module that was significantly related to tumor grade, pathologic_T stage, and clinical stage was identified. Thereafter, enrichment analysis of genes in this module uncovered that the genes were mainly enriched in the signaling pathways involved in spliceosome and cell cycle. After that, through correlation analysis, 18 hub genes highly correlated with tumor grade, clinical stage, pathologic_T stage, and the turquoise module were selected. Meanwhile, protein–protein interaction (PPI) network was constructed by using genes in the module. Finally, three key genes, heterogeneous nuclear ribonucleoprotein L, serrate RNA effector molecule, and cyclin B2, were identified by intersecting the top 30 genes with the highest connectivity in PPI network and the previously obtained 18 hub genes in the turquoise module. Further survival analysis revealed that high expression of the three key genes predicted poor prognosis of HCC. These results indicated the direction for further research on clinical diagnosis and prognostic biomarkers of HCC.
Similar content being viewed by others
Data availability
The data used to support the findings of this study are included within the article. The data and materials in the current study are available from the corresponding author on reasonable request.
References
Torre, L. A., et al. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87–108. https://doi.org/10.3322/caac.21262.
Coskun, M. (2017). Hepatocellular carcinoma in the cirrhotic liver: Evaluation using computed tomography and magnetic resonance imaging. Experimental and Clinical Transplantation, 15, 36–44. https://doi.org/10.6002/ect.TOND16.L10.
Lang, H., et al. (2007). Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. Journal of the American College of Surgeons, 205, 27–36. https://doi.org/10.1016/j.jamcollsurg.2007.03.002.
Jiao, Y., Fu, Z., Li, Y., Meng, L., & Liu, Y. (2018). High EIF2B5 mRNA expression and its prognostic significance in liver cancer: A study based on the TCGA and GEO database. Cancer Management and Research, 10, 6003–6014. https://doi.org/10.2147/CMAR.S185459.
Byeon, H., et al. (2018). Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy. Pathology – Research and Practice, 214, 814–820. https://doi.org/10.1016/j.prp.2018.05.002.
Shen, Y., et al. (2017). Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq. Oncotarget, 8, 27976–27989. https://doi.org/10.18632/oncotarget.15855.
Cheng, J., et al. (2018). Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers. Genome Medicine, 10, 42. https://doi.org/10.1186/s13073-018-0548-z.
Kalinich, M., et al. (2017). An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 114, 1123–1128. https://doi.org/10.1073/pnas.1617032114.
Sia, D., et al. (2017). Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features. Gastroenterology, 153, 812–826. https://doi.org/10.1053/j.gastro.2017.06.007.
Tavazoie, S., Hughes, J. D., Campbell, M. J., Cho, R. J., & Church, G. M. (1999). Systematic determination of genetic network architecture. Nature Genetics, 22, 281–285. https://doi.org/10.1038/10343.
Langfelder, P., & Horvath, S. (2008). WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics, 9, 559. https://doi.org/10.1186/1471-2105-9-559.
Chen, L., et al. (2018). Identification of biomarkers associated with pathological stage and prognosis of clear cell renal cell carcinoma by co-expression network analysis. Frontiers in Physiology, 9, 399. https://doi.org/10.3389/fphys.2018.00399.
Bruix, J., Gores, G. J., & Mazzaferro, V. (2014). Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut, 63, 844–855. https://doi.org/10.1136/gutjnl-2013-306627.
Zheng, J., et al. (2017). Actual 10-year survivors after resection of hepatocellular carcinoma. Annals of Surgical Oncology, 24, 1358–1366. https://doi.org/10.1245/s10434-016-5713-2.
Wang, D., Liu, J., Liu, S., & Li, W. (2020). Identification of crucial genes associated with immune cell infiltration in hepatocellular carcinoma by weighted gene co-expression network analysis. Frontiers in Genetics, 11, 342. https://doi.org/10.3389/fgene.2020.00342.
Zhang, C., et al. (2017). The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Medical Oncology, 34, 101. https://doi.org/10.1007/s12032-017-0963-9.
Zeng, Z., Cao, Z., & Tang, Y. (2020). Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data. Oncology Letters, 20, 231. https://doi.org/10.3892/ol.2020.12094.
Venkata Subbaiah, K. C., Wu, J., Potdar, A., & Yao, P. (2019). hnRNP L-mediated RNA switches function as a hypoxia-induced translational regulon. Biochemical and Biophysical Research Communications, 516, 753–759. https://doi.org/10.1016/j.bbrc.2019.06.106.
Lv, D., et al. (2017). HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways. Oncotarget, 8, 13586–13599. https://doi.org/10.18632/oncotarget.14600.
Zhou, X., et al. (2017). HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis. Oncotarget, 8, 19342–19353. https://doi.org/10.18632/oncotarget.14258.
Klingenberg, M., et al. (2018). The long noncoding RNA cancer susceptibility 9 and RNA binding protein heterogeneous nuclear ribonucleoprotein L form a complex and coregulate genes linked to AKT signaling. Hepatology, 68, 1817–1832. https://doi.org/10.1002/hep.30102.
Wilson, M. D., et al. (2008). ARS2 is a conserved eukaryotic gene essential for early mammalian development. Molecular and Cellular Biology, 28, 1503–1514. https://doi.org/10.1128/MCB.01565-07.
Gruber, J. J., et al. (2009). Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation. Cell, 138, 328–339. https://doi.org/10.1016/j.cell.2009.04.046.
Yin, J., et al. (2020). ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages. Nature Communications, 11, 2978. https://doi.org/10.1038/s41467-020-16789-2.
Chen, Y., et al. (2018). Ars2 promotes cell proliferation and tumorigenicity in glioblastoma through regulating miR-6798-3p. Scientific Reports, 8, 15602. https://doi.org/10.1038/s41598-018-33905-x.
He, Q., Huang, Y., Cai, L., Zhang, S., & Zhang, C. (2014). Expression and prognostic value of Ars2 in hepatocellular carcinoma. The International Journal of Clinical Oncology, 19, 880–888. https://doi.org/10.1007/s10147-013-0642-6.
Huang, Y., Sramkoski, R. M., & Jacobberger, J. W. (2013). The kinetics of G2 and M transitions regulated by B cyclins. PLoS One, 8, e80861. https://doi.org/10.1371/journal.pone.0080861.
Lei, C. Y., Wang, W., Zhu, Y. T., Fang, W. Y., & Tan, W. L. (2016). The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer. Urologic Oncology, 34, 237.e231–210. https://doi.org/10.1016/j.urolonc.2015.11.011.
Li, R., et al. (2019). Cyclin B2 overexpression in human hepatocellular carcinoma is associated with poor prognosis. Archives of Medical Research, 50, 10–17. https://doi.org/10.1016/j.arcmed.2019.03.003.
Author information
Authors and Affiliations
Contributions
All authors contributed to data analysis, drafting and revising the article, gave final approval of the version to be published, and agreed to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Consent for publication
All authors consent to submit the manuscript for publication.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Lin, J., Zhang, F. Identification of Three Key Genes Associated with Hepatocellular Carcinoma Progression Based on Co-expression Analysis. Cell Biochem Biophys 80, 301–309 (2022). https://doi.org/10.1007/s12013-021-01028-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-021-01028-2